Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIb Study to Evaluate the Efficacy and Safety of Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA)

NCT05027581 is registered in ClinicalTrials.gov with Taiwan Bio Therapeutics Inc. as lead sponsor.

NCT NCT05027581
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05027581 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIb Study to Evaluate the Efficacy and Safety of Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA)
Lead sponsor
Taiwan Bio Therapeutics Inc.
Phase
Phase 2
Overall status
Completed
Start date
October 13, 2021
Completion date
June 4, 2025
Enrollment
72 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, knee